← Back to Search

Behavioral Intervention

REBOOT for Drug Overdose (REBOOT Trial)

N/A
Waitlist Available
Led By Phillip O Coffin, MD, MIA
Research Sponsored by San Francisco Department of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 months
Awards & highlights

REBOOT Trial Summary

This trial will test whether or not a repeated-dose brief intervention can reduce overdose and risk behaviors among naloxone recipients with opioid use disorder.

Eligible Conditions
  • Drug Overdose
  • Opioid Use Disorder

REBOOT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dates of substance use treatment
Days of substance use treatment
Modality of substance use treatment
+3 more

REBOOT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Brief Counseling InterventionExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
REBOOT
2019
N/A
~270

Find a Location

Who is running the clinical trial?

San Francisco Department of Public HealthLead Sponsor
35 Previous Clinical Trials
34,083 Total Patients Enrolled
2 Trials studying Drug Overdose
323 Patients Enrolled for Drug Overdose
Phillip O Coffin, MD, MIAPrincipal InvestigatorSan Francisco Department of Public Health
2 Previous Clinical Trials
475 Total Patients Enrolled

Media Library

Drug Overdose Research Study Groups: Control Group, Brief Counseling Intervention
REBOOT (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03838510 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
JMIR Formative ResearchJournal
“there’s No Heroin Around Anymore. It’s All Fentanyl.
McMahan, Vanessa M, Justine Arenander, Tim Matheson, Audrey M Lambert, Sarah Brennan, Traci C Green, Alexander Y Walley, and Phillip O Coffin. 2022. ““there’s No Heroin Around Anymore. It’s All Fentanyl.” Adaptation of an Opioid Overdose Prevention Counseling Approach to Address Fentanyl Overdose: Formative Study”. JMIR Formative Research. JMIR Publications Inc.. doi:10.2196/37483.
clinicaltrials.govStudy
Repeated-dose Behavioral Intervention to Reduce Opioid Overdose
Phillip Coffin, MD, MIA 2019. "Repeated-dose Behavioral Intervention to Reduce Opioid Overdose". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03838510.
~45 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top